Boston Scientific Gross Profit 2010-2024 | BSX

Boston Scientific annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Boston Scientific gross profit for the quarter ending March 31, 2024 was $2.647B, a 12.69% increase year-over-year.
  • Boston Scientific gross profit for the twelve months ending March 31, 2024 was $10.193B, a 13.21% increase year-over-year.
  • Boston Scientific annual gross profit for 2023 was $9.895B, a 13.4% increase from 2022.
  • Boston Scientific annual gross profit for 2022 was $8.726B, a 6.71% increase from 2021.
  • Boston Scientific annual gross profit for 2021 was $8.177B, a 26.81% increase from 2020.
Boston Scientific Annual Gross Profit
(Millions of US $)
2023 $9,895
2022 $8,726
2021 $8,177
2020 $6,448
2019 $7,619
2018 $7,010
2017 $6,455
2016 $5,962
2015 $5,304
2014 $5,170
2013 $4,969
2012 $4,900
2011 $4,963
2010 $5,207
2009 $5,612
Boston Scientific Quarterly Gross Profit
(Millions of US $)
2024-03-31 $2,647
2023-12-31 $2,579
2023-09-30 $2,426
2023-06-30 $2,541
2023-03-31 $2,349
2022-12-31 $2,231
2022-09-30 $2,191
2022-06-30 $2,233
2022-03-31 $2,071
2021-12-31 $2,155
2021-09-30 $2,032
2021-06-30 $2,132
2021-03-31 $1,858
2020-12-31 $1,709
2020-09-30 $1,790
2020-06-30 $1,212
2020-03-31 $1,737
2019-12-31 $2,053
2019-09-30 $1,930
2019-06-30 $1,873
2019-03-31 $1,763
2018-12-31 $1,831
2018-09-30 $1,721
2018-06-30 $1,751
2018-03-31 $1,707
2017-12-31 $1,735
2017-09-30 $1,585
2017-06-30 $1,625
2017-03-31 $1,510
2016-12-31 $1,573
2016-09-30 $1,511
2016-06-30 $1,487
2016-03-31 $1,391
2015-12-31 $1,404
2015-09-30 $1,349
2015-06-30 $1,303
2015-03-31 $1,248
2014-12-31 $1,327
2014-09-30 $1,296
2014-06-30 $1,310
2014-03-31 $1,237
2013-12-31 $1,282
2013-09-30 $1,225
2013-06-30 $1,279
2013-03-31 $1,183
2012-12-31 $1,238
2012-09-30 $1,177
2012-06-30 $1,250
2012-03-31 $1,235
2011-12-31 $1,188
2011-09-30 $1,194
2011-06-30 $1,287
2011-03-31 $1,294
2010-12-31 $1,343
2010-09-30 $1,293
2010-06-30 $1,274
2010-03-31 $1,297
2009-12-31 $1,369
2009-09-30 $1,396
2009-06-30 $1,444
2009-03-31 $1,403
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $112.981B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.765B 23.67
Stryker (SYK) United States $129.618B 31.05
Medtronic (MDT) Ireland $100.927B 15.11
EssilorLuxottica (ESLOY) France $99.128B 0.00
Lonza Group Ag (LZAGY) Switzerland $40.585B 0.00
Haleon (HLN) United Kingdom $37.716B 27.53
ResMed (RMD) United States $28.121B 26.40
Terumo (TRUMY) Japan $24.403B 34.46
Koninklijke Philips (PHG) Netherlands $22.841B 18.13
Zimmer Biomet Holdings (ZBH) United States $22.328B 14.26
Baxter (BAX) United States $17.045B 12.12
Insulet (PODD) United States $14.134B 62.67
Smith & Nephew SNATS (SNN) United Kingdom $10.833B 0.00
Demant (WILYY) Denmark $9.370B 0.00
Bio-Rad Laboratories (BIO) United States $7.790B 25.48
BellRing Brands (BRBR) United States $7.453B 35.06
Lantheus Holdings (LNTH) United States $5.565B 13.87
GN Store Nord (GNNDY) Denmark $4.222B 23.71
Haemonetics (HAE) United States $4.215B 20.79
Perrigo (PRGO) Ireland $3.501B 10.61
Prestige Consumer Healthcare (PBH) United States $3.437B 16.35
Neogen (NEOG) United States $3.386B 32.56
ICU Medical (ICUI) United States $2.893B 25.54
Envista Holdings (NVST) United States $2.858B 11.79
TG Therapeutics (TGTX) United States $2.749B 77.35
Green Thumb Industries (GTBIF) United States $2.552B 49.96
Agios Pharmaceuticals (AGIO) United States $2.448B 0.00
QuidelOrtho (QDEL) United States $2.225B 12.35
LeMaitre Vascular (LMAT) United States $1.847B 54.13
Maravai LifeSciences Holdings (MRVI) United States $1.804B 0.00
Warby Parker (WRBY) United States $1.592B 0.00
InMode (INMD) Israel $1.532B 8.14
AdaptHealth (AHCO) United States $1.332B 9.90
Verano Holdings (VRNOF) United States $1.246B 0.00
AtriCure (ATRC) United States $1.084B 0.00
Owens & Minor (OMI) United States $1.033B 9.00
National Vision Holdings (EYE) United States $1.028B 32.72
BioLife Solutions (BLFS) United States $0.987B 0.00
Cresco Labs (CRLBF) United States $0.771B 0.00
Phibro Animal Health (PAHC) United States $0.679B 14.46
Evolus (EOLS) United States $0.679B 0.00
PetIQ (PETQ) United States $0.656B 21.21
VAREX IMAGING (VREX) United States $0.602B 14.16
Surmodics (SRDX) United States $0.599B 37.54
Quanterix (QTRX) United States $0.506B 0.00
ZimVie (ZIMV) United States $0.498B 42.44
Canopy Growth (CGC) Canada $0.491B 0.00
Valneva SE (VALN) France $0.488B 0.00
Biote (BTMD) United States $0.463B 10.67
Jin Medical (ZJYL) China $0.403B 0.00
TerrAscend (TSNDF) Canada $0.394B 0.00
Cerus (CERS) United States $0.325B 0.00
OraSure Technologies (OSUR) United States $0.315B 10.14
Zynex (ZYXI) United States $0.296B 40.52
MacroGenics (MGNX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 25.19
Aurora Cannabis (ACB) Canada $0.252B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Utah Medical Products (UTMD) United States $0.236B 14.85
Omeros (OMER) United States $0.235B 0.00
Ayr Wellness (AYRWF) United States $0.233B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Holdings (OGI) Canada $0.160B 0.00
FitLife Brands (FTLF) United States $0.153B 21.76
Capricor Therapeutics (CAPR) United States $0.153B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
Quipt Home Medical (QIPT) United States $0.137B 0.00
Veru (VERU) United States $0.123B 0.00
Jushi Holdings (JUSHF) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.104B 0.00
Fonar (FONR) United States $0.101B 10.26
Brainsway (BWAY) Israel $0.101B 0.00
InterCure (INCR) Israel $0.092B 15.46
Cellectar Biosciences (CLRB) United States $0.090B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.073B 4.75
MariMed (MRMD) United States $0.069B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.053B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Zevia PBC (ZVIA) United States $0.049B 0.00
Bright Green (BGXX) United States $0.048B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.046B 0.00
United-Guardian (UG) United States $0.041B 14.90
Cytosorbents (CTSO) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Exagen (XGN) United States $0.032B 0.00
Nephros (NEPH) United States $0.022B 0.00
Meihua Medical Technologies (MHUA) China $0.021B 0.00
Agape ATP (ATPC) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.016B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
FSD PHARMA (HUGE) Canada $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.001B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00